Hudson Bay Capital Management LP Biocryst Pharmaceuticals Inc Transaction History

Hudson Bay Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $495,600 - $814,800	-120,000 Reduced 40.0%	180,000 $1.11 Million
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $831,300 - $1.3 Million	170,000 Added 130.77%	300,000 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $323,700 - $440,050	65,000 Added 100.0%	130,000 $778,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $2,013 - $2,376	300 Added 0.46%	65,000 $460,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $154,512 - $195,582	22,200 Added 52.24%	64,700 $455,000
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $138,950 - $207,200	17,500 Added 70.0%	42,500 $354,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $262,500 - $355,000	25,000 New	25,000 $287,000
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $407,400 - $1.28 Million	-140,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.38 - $9.72 $73,800 - $97,200	10,000 Added 7.69%	140,000 $1.14 Million
Q4 2018 Feb 13, 2019	SELL	$6.51 - $9.6 $585,900 - $864,000	-90,000 Reduced 40.91%	130,000 $1.05 Million
Q3 2018 Nov 14, 2018	SELL	$5.52 - $7.99 $441,599 - $639,200	-80,000 Reduced 26.67%	220,000 $1.68 Million
Q2 2018 Aug 13, 2018	SELL	$4.6 - $6.52 $1.2 Million - $1.7 Million	-260,000 Reduced 46.43%	300,000 $1.72 Million
Q1 2018 May 14, 2018	BUY	$4.35 - $5.82 $2.44 Million - $3.26 Million	560,000 New	560,000 $2.67 Million

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.